Advertisement
Australia markets open in 1 hour 31 minutes
  • ALL ORDS

    7,861.00
    -1.30 (-0.02%)
     
  • AUD/USD

    0.6438
    +0.0035 (+0.54%)
     
  • ASX 200

    7,605.60
    -6.90 (-0.09%)
     
  • OIL

    82.87
    +0.18 (+0.22%)
     
  • GOLD

    2,381.10
    -7.30 (-0.31%)
     
  • Bitcoin AUD

    95,301.53
    -3,679.20 (-3.72%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

5 Stocks to Keep a Tab on for Solid Earnings Acceleration

Companies exhibiting continuous earnings growth will continue to enthrall almost everyone in the investment world, from top brass to research analysts. This is because earnings are a measure of the money a company is making. Still, earnings acceleration works better when it comes to lifting the stock price.

Studies have shown that most successful stocks have seen an acceleration in earnings before an uptick in the stock price. Some of the notable companies to have witnessed solid earnings acceleration as of now are Catalyst Pharmaceuticals CPRX, Warby Parker WRBY, MakeMyTrip Limited MMYT, Brookfield Renewable Partners BEP & Century Aluminum CENX.

Earnings acceleration, in fact, is the incremental growth in a company’s earnings per share (EPS). In other words, if the rate of a company’s quarter-over-quarter earnings growth increases within a stipulated frame of time, it can be called earnings acceleration.

In case of earnings growth, you pay for something that is already reflected in the stock price. But earnings acceleration helps spot stocks that haven’t yet caught the attention of investors. Once secured, it will invariably lead to a rally in the share price. This is because earnings acceleration considers both the direction and magnitude of growth rates.

ADVERTISEMENT

An increasing percentage of earnings growth means that the company is fundamentally sound and has been on the right track for a considerable period. Meanwhile, a sideways percentage of earnings growth indicates a period of consolidation or slowdown, while a decelerating percentage of earnings growth may sometimes drag prices down.

Screening Parameters

Let us look at stocks for which the last two quarter-over-quarter percentage EPS growth rates exceed the previous periods’ growth rates. The projected quarter-over-quarter percentage EPS growth rates are also expected to be higher than the previous periods’ growth rates.

EPS % Projected Growth (Q1)/(Q0) greater than EPS % Growth (Q0)/(Q-1): The projected growth rate for the current quarter (Q1) over the completed quarter (Q0) has to be greater than the growth rate from the completed quarter (Q0) over one quarter ago (Q-1).

EPS % Growth (Q0)/(Q-1) greater than EPS % Growth (Q-1)/(Q-2): The growth rate for the completed quarter (Q0) over one quarter ago (Q-1) has to be greater than the growth rate from one quarter ago (Q-1) over two quarters ago (Q-2).

EPS % Growth (Q-1)/(Q-2) greater than EPS % Growth (Q-2)/(Q-3): The growth rate from one quarter ago (Q-1) over two quarters ago (Q-2) has to be greater than the growth rate from two quarters ago (Q-2) over three quarters ago (Q-3).

In addition to this, we have added the following parameters:

Current Price greater than or equal to $5: This screens out low-priced stocks.

Average 20-day volume greater than or equal to 50,000: High trading volume implies that the stocks have adequate liquidity.

The above criteria narrowed down the universe of around 7,735 stocks to only 12. Here are five of the 12 stocks that are worth a look:

Catalyst Pharmaceuticals is a development-stage biopharmaceutical company. The company currently has a Zacks Rank #3 (Hold). CPRX’s expected earnings growth rate for the current year is 94.7%. You can see the complete list of today’s Zacks #1 (Strong Buy) Rank stocks here.

Warby Parker is a direct-to-consumer eyewear brand. The company currently has a Zacks Rank #3. WRBY’s expected earnings growth rate for the current year is 500%.

MakeMyTrip Limited is an online travel service company that offers travel products and solutions in India and the United States. The company currently has a Zacks Rank #2 (Buy). MMYT’s expected earnings growth rate for the current year is 85%.

Brookfield Renewable Partners owns and operates a renewable power platform. The company currently has a Zacks Rank #3. BEP’s expected earnings growth rate for the current year is 95%.

Century Aluminum is engaged in the production of primary aluminum in the United States and Iceland. The company currently has a Zacks Rank #3. CENX’s expected earnings growth rate for the current year is 107.7%.

You can sign up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge.

Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.

Click here to sign up for a free trial to the Research Wizard today.

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

Disclosure: Performance information for Zacks’ portfolios and strategies are available at: https://www.zacks.com/performance

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

MakeMyTrip Limited (MMYT) : Free Stock Analysis Report

Catalyst Pharmaceuticals, Inc. (CPRX) : Free Stock Analysis Report

Century Aluminum Company (CENX) : Free Stock Analysis Report

Brookfield Renewable Partners L.P. (BEP) : Free Stock Analysis Report

Warby Parker Inc. (WRBY) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research